FENNEC PHARMACEUTICALS INC. (FENC)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $160k
- Sep 15 · Routine
- Form 4 sales
- 71
- On record
- Form 144 notices
- 13
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualMay 11 2026
Sold 8,346 shares at $7.04 ($59k)
Rallis Chris A, Director
10b5-1 planSold 11.7% of holdings ($503k position)63,077 shares left5.9x usual sizeFiling
- 2 Form 4 saleRoutineJun 1 +21 days
Sold 9,747 shares at $9.62 ($94k)
Raykov Rosty, Director
10b5-1 planSold 7% of holdings ($1.3M position)130,079 shares left1x usual sizeFiling
- 3 Form 4 saleRoutineJul 1 +30 days
Sold 9,599 shares at $10.41 ($100k)
Raykov Rosty, Other
10b5-1 planSold 6.5% of holdings ($1.5M position)138,855 shares left1x usual sizeFiling
- 4 Form 4 saleRoutineAug 3 +33 days
Sold 10,000 shares at $9.58 ($96k)
Raykov Rosty, Other
10b5-1 planSold 7.1% of holdings ($1.4M position)131,633 shares left1x usual sizeFiling
- 5 Form 4 saleRoutineAug 27 +24 days
Sold 75,000 shares at $11.78 ($884k)
Andrade Robert, CHIEF FINANCIAL OFFICER
10b5-1 planSold 25.6% of holdings ($3.4M position)217,675 shares leftFirst sale on recordFiling
- 6 Form 4 saleUnusualAug 31 +4 days
Sold 12,000 shares at $12.18 ($146k)
Sayad Pierre Sargis, Chief Medical Officer
No 10b5-1 planSold 55.8% of holdings ($262k position)9,519 shares leftFirst sale on recordFiling
- 7 Form 4 saleRoutineSep 1 +1 day
Sold 10,000 shares at $12.11 ($121k)
Raykov Rosty, Other
10b5-1 planSold 7.4% of holdings ($1.6M position)124,411 shares left1x usual sizeFiling
- 8 Form 4 saleRoutineSep 15 +14 days
Sold 15,545 shares at $10.29 ($160k)
Brughera Marco Maria, Director
10b5-1 planSold 100% of holdings ($160k position)0 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (84)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Brughera Marco Maria | Director | Form 4 sale | 15,545 | $160k | 100.0% | Routine | SEC |
| Sep 1, 2026 | Raykov Rosty | Other | Form 4 sale | 10,000 | $121k | 7.4% | Routine | SEC |
| Aug 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Form 4 sale | 12,000 | $146k | 55.8% | Unusual | SEC |
| Aug 27, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Form 4 sale | 75,000 | $884k | 25.6% | Routine | SEC |
| Aug 3, 2026 | Raykov Rosty | Other | Form 4 sale | 10,000 | $96k | 7.1% | Routine | SEC |
| Jul 1, 2026 | Raykov Rosty | Other | Form 4 sale | 9,599 | $100k | 6.5% | Routine | SEC |
| Jun 1, 2026 | Raykov Rosty | Director | Form 4 sale | 9,747 | $94k | 7.0% | Routine | SEC |
| May 11, 2026 | Rallis Chris A | Director | Form 4 sale | 8,346 | $59k | 11.7% | Unusual | SEC |
| May 1, 2026 | Raykov Rosty | Director | Form 4 sale | 10,781 | $70k | 8.2% | Routine | SEC |
| Apr 1, 2026 | Raykov Rosty | Director | Form 4 sale | 10,946 | $69k | 8.8% | Routine | SEC |
| Mar 2, 2026 | Raykov Rosty | Director | Form 4 sale | 10,079 | $84k | 8.8% | Routine | SEC |
| Feb 2, 2026 | Raykov Rosty | Director | Form 4 sale | 10,349 | $80k | 9.5% | Routine | SEC |
| Jan 2, 2026 | Raykov Rosty | Director | Form 4 sale | 10,312 | $78k | 10.5% | Routine | SEC |
| Dec 24, 2025 | Southpoint Capital Advisors LP | 10% owner | Form 4 sale | 1M | $7.5M | 26.7% | Unusual | SEC |
| Dec 5, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $75k | 11.4% | Routine | SEC |
| Nov 18, 2025 | Southpoint Capital Advisors LLC | 10% owner | Form 4 sale | 19,341 | $170k | 0.5% | No plan | SEC |
| Nov 17, 2025 | Southpoint GP, LLC | 10% owner | Form 4 sale | 246,018 | $2M | 6.1% | No plan | SEC |
| Nov 5, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $81k | 10.8% | Routine | SEC |
| Oct 10, 2025 | Rallis Chris A | Director | Form 4 sale | 1,775 | $16k | 3.0% | Routine | SEC |
| Oct 9, 2025 | Southpoint Capital Advisors LLC | 10% owner | Form 4 sale | 67,114 | $636k | 1.6% | No plan | SEC |
| Oct 6, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $98k | 10.8% | Routine | SEC |
| Sep 4, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $89k | 16.4% | Routine | SEC |
| Aug 5, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $81k | 15.2% | Routine | SEC |
| Jul 7, 2025 | Rallis Chris A | Director | Form 4 sale | 1,119 | $10k | 2.0% | Routine | SEC |
| Jul 3, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $86k | 14.2% | Routine | SEC |
| Jun 5, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $78k | 13.3% | Routine | SEC |
| May 16, 2025 | Raykov Rosty | Director | Form 4 sale | 16,667 | $113k | 19.2% | Unusual | SEC |
| May 5, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $63k | 15.7% | Unusual | SEC |
| Apr 11, 2025 | Rallis Chris A | Director | Form 4 sale | 1,409 | $7k | 2.6% | Routine | SEC |
| Apr 4, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $53k | 14.1% | Unusual | SEC |
| Mar 5, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $68k | 12.7% | Unusual | SEC |
| Feb 14, 2025 | Rallis Chris A | Director | Form 4 sale | 1,186 | $8k | 2.2% | Routine | SEC |
| Feb 5, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $67k | 11.6% | Unusual | SEC |
| Jan 6, 2025 | Raykov Rosty | Director | Form 4 sale | 10,000 | $61k | 10.7% | Unusual | SEC |
| Dec 5, 2024 | Raykov Rosty | Director | Form 4 sale | 796 | $5k | 1.2% | Routine | SEC |
| Dec 5, 2024 | Raykov Rosty | Director | Form 144 notice | 796 | $5k | Notice | SEC | |
| Dec 3, 2024 | Raykov Rosty | Director | Form 4 sale | 1,635 | $10k | 2.4% | Routine | SEC |
| Dec 3, 2024 | Raykov Rosty | Director | Form 144 notice | 1,635 | $10k | Notice | SEC | |
| Dec 2, 2024 | Rallis Chris A | Director | Form 4 sale | 6,409 | $39k | 10.9% | Routine | SEC |
| Dec 2, 2024 | Rallis Chris A | Director | Form 144 notice | 6,409 | $39k | Notice | SEC | |
| Nov 4, 2024 | Raykov Rosty | Director | Form 4 sale | 2,431 | $10k | 3.5% | Routine | SEC |
| Oct 8, 2024 | Rallis Chris A | Director | Form 4 sale | 1,406 | $6k | 2.8% | Routine | SEC |
| Oct 1, 2024 | Raykov Rosty | Director | Form 4 sale | 2,431 | $12k | 3.5% | No plan | SEC |
| Sep 4, 2024 | Raykov Rosty | Director | Form 4 sale | 2,431 | $13k | 3.5% | No plan | SEC |
| Aug 1, 2024 | Raykov Rosty | CHIEF EXECUTIVE OFFICER | Form 4 sale | 2,431 | $15k | 1.3% | No plan | SEC |
| Jul 5, 2024 | Rallis Chris A | Director | Form 4 sale | 1,173 | $7k | 2.5% | Routine | SEC |
| Jul 2, 2024 | Raykov Rosty | CHIEF EXECUTIVE OFFICER | Form 4 sale | 2,431 | $15k | 1.3% | Routine | SEC |
| Jun 3, 2024 | Raykov Rosty | CHIEF EXECUTIVE OFFICER | Form 4 sale | 2,431 | $16k | 1.3% | Routine | SEC |
| May 1, 2024 | Raykov Rosty | CHIEF EXECUTIVE OFFICER | Form 4 sale | 2,431 | $22k | 1.3% | Routine | SEC |
| Apr 22, 2024 | Haigh Adrian | CHIEF OPERATING OFFICER | Form 4 sale | 44,445 | $415k | 100.0% | Routine | SEC |
| Apr 18, 2024 | Haigh Adrian | CHIEF OPERATING OFFICER | Form 4 sale | 44,444 | $434k | 100.0% | Routine | SEC |
| Apr 16, 2024 | Haigh Adrian | CHIEF OPERATING OFFICER | Form 4 sale | 44,444 | $457k | 100.0% | Routine | SEC |
| Apr 15, 2024 | Rallis Chris A | Director | Form 4 sale | 800 | $8k | 1.8% | Routine | SEC |
| Apr 5, 2024 | Raykov Rosty | CHIEF EXECUTIVE OFFICER | Form 4 sale | 88,583 | $958k | 32.1% | Unusual | SEC |
| Apr 3, 2024 | Raykov Rosty | CHIEF EXECUTIVE OFFICER | Form 4 sale | 40,584 | $437k | 12.8% | Routine | SEC |
| Mar 26, 2024 | Rallis Chris A | Director | Form 4 sale | 2,114 | $23k | 4.9% | Routine | SEC |
| Mar 26, 2024 | Andrade Robert | CHIEF FINANCIAL OFFICER | Form 4 sale | 13,975 | $152k | 13.2% | No plan | SEC |
| Mar 25, 2024 | Andrade Robert | CHIEF FINANCIAL OFFICER | Form 4 sale | 13,975 | $154k | 11.7% | Routine | SEC |
| Jan 5, 2024 | Andrade Robert | Officer | Form 144 notice | 15,000 | $156k | Notice | SEC | |
| Jan 5, 2024 | Andrade Robert | CHIEF FINANCIAL OFFICER | Form 4 sale | 30,000 | $316k | 20.0% | Routine | SEC |
| Jan 4, 2024 | Andrade Robert | Officer | Form 144 notice | 15,000 | $160k | Notice | SEC | |
| Dec 28, 2023 | Raykov Rosty | CHIEF EXECUTIVE OFFICER | Form 4 sale | 3,656 | $42k | 1.3% | No plan | SEC |
| Dec 28, 2023 | Raykov Rosty | Officer | Form 144 notice | 3,656 | $36k | Notice | SEC | |
| Dec 26, 2023 | Rallis Chris A | Director | Form 4 sale | 1,390 | $15k | 3.0% | Routine | SEC |
| Nov 20, 2023 | Rallis Chris A | Director | Form 4 sale | 269 | $2k | 0.6% | Routine | SEC |
| Nov 8, 2023 | Raykov Rosty | CHIEF EXECUTIVE OFFICER | Form 4 sale | 25,044 | $194k | 8.1% | No plan | SEC |
| Nov 8, 2023 | Raykov Rosty | Officer | Form 144 notice | 50,000 | $348k | Notice | SEC | |
| Aug 18, 2023 | Rallis Chris A | Director | Form 4 sale | 673 | $5k | 1.5% | Routine | SEC |
| Aug 18, 2023 | Rallis Chris A | Director | Form 144 notice | 673 | $5k | Notice | SEC | |
| Jul 24, 2023 | Rallis Chris A | Director | Form 4 sale | 6,796 | $56k | 13.4% | Unusual | SEC |
| Jul 24, 2023 | Rallis Chris A | Director | Form 144 notice | 6,796 | $56k | Notice | SEC | |
| Jul 6, 2023 | Rallis Chris A | Director | Form 4 sale | 2,207 | $19k | 7.1% | Routine | SEC |
| Jun 30, 2023 | Andrade Robert | Officer | Form 144 notice | 7,500 | $66k | Notice | SEC | |
| Jun 30, 2023 | Andrade Robert | CHIEF FINANCIAL OFFICER | Form 4 sale | 25,000 | $223k | 16.7% | Routine | SEC |
| Jun 29, 2023 | Andrade Robert | Officer | Form 144 notice | 7,500 | $67k | Notice | SEC | |
| Jun 28, 2023 | Andrade Robert | Officer | Form 144 notice | 10,000 | $90k | Notice | SEC | |
| May 19, 2023 | Rallis Chris A | Director | Form 4 sale | 1,758 | $13k | 5.4% | Routine | SEC |
| Apr 17, 2023 | Rallis Chris A | Director | Form 144 notice | 986 | $8k | Notice | SEC | |
| Dec 30, 2022 | Raykov Rosty | CHIEF EXECUTIVE OFFICER | Form 4 sale | 28,740 | $276k | 11.7% | Plan not stated | SEC |
| Dec 30, 2022 | Andrade Robert | CHIEF FINANCIAL OFFICER | Form 4 sale | 22,000 | $211k | 12.8% | Plan not stated | SEC |
| Nov 17, 2022 | Rallis Chris A | Director | Form 4 sale | 333 | $3k | 1.1% | Plan not stated | SEC |
| Mar 28, 2018 | Besser James E | 10% owner | Form 4 sale | 914,745 | $9.7M | 35.4% | Unusual | SEC |
| Mar 6, 2018 | Manchester Management Co LLC | 10% owner | Form 4 sale | 70,100 | $647k | 3.1% | Plan not stated | SEC |
| Jun 8, 2010 | Southpoint GP, LLC | 10% owner | Form 4 sale | 41.5M | 17.2% | Plan not stated | SEC |